Mary C. Tanner

Bear, Stearns & Co., Inc. is a global investment banking, securities trading and brokerage firm located in New York City with additional offices in Dallas, Boston and San Francisco. The firm is a subsidiary Bear Sterns Cos., Inc. (NYSE: BSC). Their equity research team consists of senior analysts located throughout the world. In addition to domestic coverage, they have research teams focusing on Latin America, Asia and Europe. The analysts use a bottom-up approach to stock selection. The Bear Stearns fixed-income research department provides coverage of every sector of the fixed-income universe. The financial analytics and structured transactions group (F.A.S.T) provides investment research, fixed-income portfolio management and analytical systems, trading technology and general financial expertise. The group also provides a broad range of services to financial institutions including asset-liability management, balance sheet restructuring, receivables-based financing analysis, security and portfolio analysis, peer analysis, and historical and real-time market-based information.

A subsidiary of Lehman Brothers Holdings, Inc., Lehman Brothers, Inc. is a broker/dealer headquartered in New York City. They provide global equity and fixed research. The equity research department covers more than 100 sectors. They use a fundamental, quantitative, strategic and tactical research approach. In addition to these Lehman has also developed special products, such as 10 uncommon values and 10 uncommon eurovalues.

ARIAD Pharmaceuticals, Inc. operates as an oncology company, which engages in the discovery, development, and commercialization of small-molecule drugs for the treatment of cancer. The company was founded by Harvey J. Berger and James E. Rothman on January 8, 1992 and is headquartered in Cambridge, MA.

HaptoGuard, Inc. develops and commercializes therapeutics for inflammatory diseases. Its products include orally bioavailability and organ selenium mimics of glutathione peroxides that metabolize lipid peroxides. It develops products to research, diagnose, treat, and prevent diseases associated with damage from free radical and reactive oxygen species and diseases of oxidative stress. The company is headquartered in Fort Lee, NJ.

Lineagen, Inc. provides diagnostic evaluation services. It focuses on genetic disorders such as autism, multiple sclerosis, and chronic obstructive pulmonary diseases. The firm provides FirstStep, which provides physicians with integrated genetic testing, counseling, and developmental screening services. The company was founded by Stephen M. Prescott, Andy Peiffer, Michael S. Paul, Mark F. Leppert, Al R. Harris and Alex S. Lindell in 2006 and is headquartered in Salt Lake City, UT.